Martinez Laura, Khavari Rose
Houston Methodist Hospital, Department of Urology, 6560 Fannin, Suite 2100, Houston, Texas 77030.
Curr Bladder Dysfunct Rep. 2017 Dec;12(4):291-297. doi: 10.1007/s11884-017-0429-0. Epub 2017 Aug 4.
Diagnosis of bladder outlet obstruction (BOO) often presents a challenge in female patients. Traditional diagnostic elements such as symptom history and urodynamic data are rarely clear cut in women. Therefore, we sought to review the current literature on diagnosis of female BOO, focusing on new frontiers in the realm of molecular markers and imaging modalities.
In addition to fluoroscopy in the setting of videourodynamics, ultrasound and MRI can augment the diagnosis and aid in therapeutic planning in certain etiologies of female BOO. Furthermore, multiple potential biomarkers (i.e. nerve growth factor, prostaglandins, ATP) that have been studied in correlation to BOO in animal models as well as human subjects hold promise for diagnostic applications.
These novel techniques may augment standard clinical and urodynamic evaluation of BOO in females. Future directions include further studies of each of these biomarkers in female patients with BOO compared to normal controls to test their feasibility as potential screening tools.
膀胱出口梗阻(BOO)的诊断在女性患者中常常是一项挑战。诸如症状史和尿动力学数据等传统诊断要素在女性中很少是明确的。因此,我们试图回顾当前关于女性BOO诊断的文献,重点关注分子标志物和成像方式领域的新前沿。
除了在影像尿动力学检查中进行荧光透视检查外,超声和磁共振成像(MRI)可以加强诊断,并有助于针对女性BOO的某些病因进行治疗规划。此外,在动物模型以及人类受试者中,已经研究了多种与BOO相关的潜在生物标志物(即神经生长因子、前列腺素、三磷酸腺苷(ATP)),它们在诊断应用方面具有前景。
这些新技术可能会加强对女性BOO的标准临床和尿动力学评估。未来的方向包括,将这些生物标志物中的每一种在患有BOO的女性患者与正常对照中进行进一步研究,以测试它们作为潜在筛查工具的可行性。